- Home
- FRSX vs APRE Comparison
FRSX vs APRE Comparison
Compare FRSX & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- APRE
- Stock Information
- Founded
- FRSX N/A
- APRE 2006
- Country
- FRSX Israel
- APRE United States
- Employees
- FRSX N/A
- APRE N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRSX Technology
- APRE Health Care
- Exchange
- FRSX Nasdaq
- APRE Nasdaq
- Market Cap
- FRSX 7.7M
- APRE 6.9M
- IPO Year
- FRSX 2017
- APRE 2019
- Fundamental
- Price
- FRSX $2.20
- APRE $1.18
- Analyst Decision
- FRSX
- APRE Strong Buy
- Analyst Count
- FRSX 0
- APRE 1
- Target Price
- FRSX N/A
- APRE $20.00
- AVG Volume (30 Days)
- FRSX 20.5K
- APRE 148.6K
- Earning Date
- FRSX 11-13-2025
- APRE 11-12-2025
- Dividend Yield
- FRSX N/A
- APRE N/A
- EPS Growth
- FRSX N/A
- APRE N/A
- EPS
- FRSX N/A
- APRE N/A
- Revenue
- FRSX $452,000.00
- APRE $488,239.00
- Revenue This Year
- FRSX N/A
- APRE N/A
- Revenue Next Year
- FRSX N/A
- APRE N/A
- P/E Ratio
- FRSX N/A
- APRE N/A
- Revenue Growth
- FRSX N/A
- APRE N/A
- 52 Week Low
- FRSX $1.98
- APRE $1.15
- 52 Week High
- FRSX $18.41
- APRE $5.00
- Technical
- Relative Strength Index (RSI)
- FRSX 45.61
- APRE 36.10
- Support Level
- FRSX $2.12
- APRE $1.21
- Resistance Level
- FRSX $2.33
- APRE $1.32
- Average True Range (ATR)
- FRSX 0.09
- APRE 0.07
- MACD
- FRSX -0.03
- APRE -0.02
- Stochastic Oscillator
- FRSX 12.77
- APRE 16.96
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.